FDA Adverse Event Death Summary report: N

MEPILEX AND/OR MEPILEX AG

MDR report key: 3457420 · Received October 30, 2013

Report

Report Number
3004763499-2013-00019
Event Type
Death
Date Received
October 30, 2013
Date of Event
March 28, 2013
Report Date
October 29, 2013
Manufacturer
MOLNLYCKE HEALTH CARE
Product Code
FRO
PMA / PMN Number
EXEMPT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THIS WAS A DOUBLE-BLINDED, COMPARATIVE, SUPERIORITY, MULTI-CENTER CLINICAL INVESTIGATION OF MEPILEX AND MEPILEX AG CONDUCTED IN (B)(4). BASED ON THE AVAILABLE INFO, THIS EVENT IS DEEMED A SERIOUS INJURY. AS THIS WAS A DOUBLE-BLINDED STUDY WE ARE NOT AT THIS TIME SURE OF WHICH OF THE DEVICES WAS USED ON THIS SUBJECT. THEREFORE, WE HAVE REPORTED ON BOTH PRODUCTS. NO ADD'L PT / EVENT INFO HAS BEEN PROVIDED TO DATE. THE INVESTIGATORS ASSESSMENT OF RELATIONSHIP OF SUBJECT INCIDENT RELATION TO PRODUCT IS UNLIKELY. SHOULD ADD'L INFO BECOME AVAILABLE, A F/U REPORT WILL BE SUBMITTED.

Description of Event or Problem · 1

PT WAS ENROLLED IN A DOUBLE-BLINDED, COMPARATIVE, SUPERIORITY, MULTI-CENTER CLINICAL INVESTIGATION OF MEPILEX AND MEPILEX AG. THE SUBJECT DIED FROM CARDIAC DECOMPENSATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
556127 MEPILEX AND/OR MEPILEX AG MEPILEX AND/OR MEPILEX AG FRO MOLNLYCKE HEALTH CARE NA UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Death